PREVIFEM Drug Patent Profile
✉ Email this page to a colleague
When do Previfem patents expire, and what generic alternatives are available?
Previfem is a drug marketed by Vintage Pharms Llc and is included in one NDA.
The generic ingredient in PREVIFEM is ethinyl estradiol; norgestimate. There are twenty-six drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norgestimate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PREVIFEM?
- What are the global sales for PREVIFEM?
- What is Average Wholesale Price for PREVIFEM?
Summary for PREVIFEM
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 6 |
Clinical Trials: | 1 |
Drug Prices: | Drug price information for PREVIFEM |
Drug Sales Revenues: | Drug sales revenues for PREVIFEM |
DailyMed Link: | PREVIFEM at DailyMed |
![PREVIFEM drug patent expirations Drug patent expirations by year for PREVIFEM](/p/graph/s/t/PREVIFEM-patent-expirations.png)
![Drug Prices for PREVIFEM](/p/graph/drug-price/PREVIFEM.png)
![Drug Sales Revenue Trends for PREVIFEM](/p/graph/drug-sales-revenues/PREVIFEM.png)
Recent Clinical Trials for PREVIFEM
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Virginia Commonwealth University | Phase 4 |
American Heart Association | Phase 4 |
US Patents and Regulatory Information for PREVIFEM
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Vintage Pharms Llc | PREVIFEM | ethinyl estradiol; norgestimate | TABLET;ORAL-28 | 076334-001 | Jan 9, 2004 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |